Home Sleep Apnea Testing Patents: Who Leads 2026
Home Sleep Apnea Testing Patents: Filing Trends and Who Leads
70.6% concentration. The top 5 assignees combined account for 48 of the 68 records in scope — a field with a clear head, not a diffuse one. Filings stayed at zero or near-zero through 2017-2020, then rose from 1 in 2021 to a peak of 21 in 2023, with 2024 — the last complete year — at 17, a +1600% increase over the 2021-2024 span. Read the final one to two years as incomplete rather than declining.
- 1UNIV OF WASHINGTON17
- 2KONINKLIJKE PHILIPS NV13
- 3ECTOSENSE NV8
- 4NOX MEDICAL EHF5
- 5RGT UNIV OF CALIFORNIA5
See the full home sleep apnea testing analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Frequently asked questions
How many patents cover home sleep apnea testing?
The dataset used for this landscape contains 68 published records filed between 2015 and mid-2026, drawn from US, PCT, EPO and national filing offices. This counts patent families rather than raw document duplicates, which gives a fairer picture than counting every continuation or national-phase filing separately. Coverage runs up to a 2026-07-31 data cut-off, so the most recent months are still incomplete.
Who are the leading patent holders in home sleep apnea testing?
Thirty assignees make up the full ranked list returned for this dataset, and the top 5 combined hold 70.6% of all 68 records in scope, with the top 10 accounting for the entire set. The leading assignee alone holds 17 records, well ahead of the fifth-ranked entrant at 5. This is a concentrated field with a clear leader-plus-tail structure rather than one spread evenly across many small filers.
Is the home sleep apnea testing patent field growing or slowing down?
Filings grew sharply, from 1 in 2021 to 17 in 2024, a +1600% increase over that span, with a peak of 21 filings in 2023. The apparent dip in 2025 and 2026 is an artefact of publication lag, which typically runs about 18 months behind actual filing, not a genuine slowdown. Any read of the trend should treat 2024 as the last complete year.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Home Sleep Apnea Testing covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.